Source: Health Canada shortage reports · Updated Jul 29, 2026
Canagliflozin is in a widespread shortage in Canada. 2 of 4 reported products are affected. The latest manufacturer estimate for full recovery is Jan 8, 2027.
A diabetes medication (SGLT2 inhibitor) used to help control blood sugar in type 2 diabetes.
Products affected
2 / 4
In shortage since
Mar 10, 2026
Est. full return
Jan 8, 2027
Reports on file
8
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
JAMP CANAGLIFLOZIN
100MG · TABLET · JAMP PHARMA CORPORATION
DIN 02543486 · since Mar 10, 2026, est. end Jan 8, 2027 · Demand increase for the drug.
Active shortage
JAMP CANAGLIFLOZIN
100MG · TABLET · JAMP PHARMA CORPORATION
DIN 02543486 · since Mar 10, 2026, est. end Jan 8, 2027 · Demand increase for the drug.
Active shortage
JAMP CANAGLIFLOZIN
300MG · TABLET · JAMP PHARMA CORPORATION
DIN 02543494 · since Mar 10, 2026, est. end Dec 4, 2026 · Demand increase for the drug.
Active shortage
JAMP CANAGLIFLOZIN
300MG · TABLET · JAMP PHARMA CORPORATION
DIN 02543494 · since Mar 10, 2026, est. end Dec 4, 2026 · Demand increase for the drug.
Active shortage
JAMP CANAGLIFLOZIN
300MG · TABLET · JAMP PHARMA CORPORATION
DIN 02543494 · since Mar 10, 2026, est. end Dec 4, 2026 · Demand increase for the drug.
Resolved
AURO-CANAGLIFLOZIN
300MG · TABLET · AURO PHARMA INC
DIN 02510375 · ended Apr 20, 2026 · Demand increase for the drug.
Resolved
AURO-CANAGLIFLOZIN
100MG · TABLET · AURO PHARMA INC
DIN 02510367 · ended Mar 26, 2026 · Demand increase for the drug.
Resolved
AURO-CANAGLIFLOZIN
300MG · TABLET · AURO PHARMA INC
DIN 02510375 · ended Mar 25, 2026 · Demand increase for the drug.
What's happening
Canagliflozin is currently affected by 2 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION.
The reported cause is: demand increase for the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Canagliflozin is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BK).
Recent changes
Jul 29, 2026
Estimated end date pushed back : Jul 10, 2026 → Jan 8, 2027
Jul 29, 2026
Estimated end date pushed back : Jul 10, 2026 → Jan 8, 2027
Common questions
What is Canagliflozin used for?
A diabetes medication (SGLT2 inhibitor) used to help control blood sugar in type 2 diabetes.
When will Canagliflozin be back in stock in Canada?
The latest manufacturer estimate is Jan 8, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Canagliflozin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.